array CGH

Denmark-based Arcedi would like to commercialize its technology through a major diagnostic company.

NanoVelcro chip

A UCLA group and spinout FetoLumina Technologies are working on a clinical assay for noninvasive prenatal diagnostics.  

The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business.